EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the fourth leading cause of cancer‐related death worldwide. Our previous study showed that EYA4 functioned by suppressing growth of HCC tumor cells, but its molecular mechanism is still not elucidated. Based on the results of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Zhu, Xiao‐Xu, Li, Jian‐Hui, Cai, Jian‐Peng, Hou, Xun, Huang, Chen‐Song, Huang, Xi‐Tai, Wang, Jie‐Qin, Li, Shi‐Jin, Xu, Qiong‐Cong, Yin, Xiao‐Yu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://ncbi.nlm.nih.gov/pubmed/31385398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14159
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia